Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,018 total articles

Insider Activity at Church & Dwight Co.: Director Penry Price Sells Shares Amid Strong Quarterly Performance

Insider Activity at Church & Dwight Co.: Director Penry Price Sells Shares Amid Strong Quarterly Performance

Director Penry W. Price of Church & Dwight Co. Inc. (NASDAQ:CHD) recently sold a significant block of common stock following the exercise of options. This transaction occurred against a backdrop of strong financial performance for the company in the first quarter of 2026, where adjusted earnings per share and revenue both exceeded market expect…

CEL-SCI CEO Buys Shares Amid Stock Downturn; Company Reports Major Financial and Commercial Activity

CEL-SCI CEO Buys Shares Amid Stock Downturn; Company Reports Major Financial and Commercial Activity

The Chief Executive Officer of CEL SCI CORP (NASDAQ:CVM), Geert R. Kersten, purchased 100,000 shares of the company's common stock on May 13, 2026, representing an investment of $119,000. This insider transaction occurs while the stock is trading near its 52-week low and has experienced significant declines over the last week and year. Separately, …

Watts Water Technologies Executive Sells Shares Amid Stock Rise

Watts Water Technologies Executive Sells Shares Amid Stock Rise

Executive activity at Watts Water Technologies Inc. (NYSE:WTS) has drawn attention following the sale of shares by President for APAC, Middle East, and Africa, Elie Melhem. The transaction occurred while the company's stock price remains elevated. Separately, WTS reported a strong first-quarter 2026, with adjusted EPS and revenue both surpassing an…

FTI Consulting CFO Nam's Stock Acquisition Amid Market Dip

FTI Consulting CFO Nam's Stock Acquisition Amid Market Dip

Eun Nam, Chief Financial Officer of FTI Consulting, Inc., recently acquired shares of the company's common stock. This insider transaction occurred while the stock was trading near its 52-week low. Despite an earnings per share (EPS) figure that fell short of expectations in Q1 2026, the firm exceeded revenue forecasts and announced several strateg…

FTI Consulting Officer Buys Shares Amid Stock Dip; Company Reports Mixed Q1 Performance and Key Leadership Appointments

FTI Consulting Officer Buys Shares Amid Stock Dip; Company Reports Mixed Q1 Performance and Key Leadership Appointments

Linton Paul Alderman, Chief Strategy/Transformation Officer at FTI Consulting (NYSE:FCN), recently purchased shares of the company's common stock. This transaction occurred when the stock was trading near its 52-week minimum. Separately, FTI Consulting reported Q1 2026 earnings that provided a mixed picture, with revenue surpassing estimates but ea…

Director's Buy at ADMA Biologics Amid Valuation Questions

Director's Buy at ADMA Biologics Amid Valuation Questions

ADMA Biologics director Jerrold B. Grossman conducted an open market purchase of company stock on May 12, 2026. This transaction occurred while the common stock was trading near its 52-week low and after the company reported Q1 financial results that failed to meet market expectations. The report details his direct holdings, indirect ownership stru…

Insider Selling at Clover Health Amid Mixed Q1 Results

Insider Selling at Clover Health Amid Mixed Q1 Results

Clover Health Investments Corp. (CLOV) saw its CEO sell a substantial block of company stock in May 2026. This insider activity occurred alongside the release of Q1 2026 earnings results, where the company reported revenue exceeding expectations but missed analyst forecasts for earnings per share. The mixed financial performance provides context to…

Mineralys CMO Activity and Company Developments Offer Mixed Signals

Mineralys CMO Activity and Company Developments Offer Mixed Signals

The Chief Medical Officer of Mineralys Therapeutics, Inc., Dr. David Malcom Rodman, recently executed a series of transactions involving the company's common stock. These sales generated substantial proceeds, while simultaneous option exercises resulted in new holdings. Despite these insider movements, which were conducted under a pre-arranged trad…

Director Moore Executes Stock Transactions at Texas Roadhouse; Recent Earnings and Analyst Actions Provide Context

Director Moore Executes Stock Transactions at Texas Roadhouse; Recent Earnings and Analyst Actions Provide Context

Texas Roadhouse director Gregory N. Moore conducted multiple stock transactions on May 11, 2026, including a significant sale through the Moore Family Trust and a gift to a charitable foundation. This activity was reported alongside Texas Roadhouse's mixed Q1 2026 earnings results and subsequent analyst actions. While the company surpassed EPS expe…